Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome

Kidney International

Volumn 74, Issue 8, 2008, Pages 1017-1025

  Doi, Kent ^a   Leelahavanichkul, Asada ^a   Hu, Xuzhen ^a   Sidransky, Karen L ^a   Zhou, Hua ^a   Qin, Yan ^a   Eisner, Christoph ^a   Schnermann, Jürgen ^a   Yuen, Peter S T ^a   Star, Robert A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Acute on chronic; Cecal ligation puncture; Chloroquine; SFlt 1; VEBGF

Indexed keywords

CHLOROQUINE; CREATININE; FOLIC ACID; INTERLEUKIN 10; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTEREMIA; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HEMODYNAMICS; KIDNEY INJURY; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SEPSIS; SEPTIC SHOCK; SPLEEN CELL;

ANIMALS; CAPILLARY PERMEABILITY; CREATINE; DISEASE MODELS, ANIMAL; HEMODYNAMICS; INTERLEUKIN-10; KIDNEY DISEASES; MICE; SEPSIS; SHOCK, SEPTIC; SPLEEN; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 53049090662     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.346     Document Type: Article

References (52)

1. Angus DC, Linde-Zwirble WT, Lidicker J et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-1310.
2. Martin GS, Mannino DM, Eaton S et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554.
3. Russell JA, Singer J, Bernard GR et al. Changing pattern of organ dysfunction in early human sepsis is related to mortality. Crit Care Med 2000; 28: 3405-3411.
4. Uchino S, Kellum JA, Bellomo R et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294: 813-818.
5. Guidet B, Aegerter P, Gauzit R et al. Incidence and impact of organ dysfunctions associated with sepsis. Chest 2005; 127: 942-951.
6. Riedemann NC, Guo RF, Ward PA. The enigma of sepsis. J Clin Invest 2003; 112: 460-467.
7. Doi K, Okamoto K, Negishi K et al. Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. Am J Pathol 2006; 168: 1413-1424.
8. Miyaji T, Hu X, Yuen PS et al. Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice. Kidney Int 2003; 64: 1620-1631.
9. Yuan HT, Li XZ, Pitera JE et al. Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia-inducible factor-1 alpha. Am J Pathol 2003; 163: 2289-2301.
10. Yasuda H, Yuen PS, Hu X et al. Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int 2006; 69: 1535-1542.
11. Dear JW, Kobayashi H, Jo SK et al. Dendrimer-enhanced MRI as a diagnostic and prognostic biomarker of sepsis-induced acute renal failure in aged mice. Kidney Int 2005; 67: 2159-2167.
12. Weis SM, Cheresh DA. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005; 437: 497-504.
13. Yano K, Liaw PC, Mullington JM et al. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 2006; 203: 1447-1458.
14. Tsao PN, Chan FT, Wei SC et al. Soluble vascular endothelial growth factor receptor-1 protects mice in sepsis. Crit Care Med 2007; 35: 1955-1960.
15. Ertel W, Morrison MH, Ayala A et al. Chloroquine attenuates hemorrhagic shock-induced immunosuppression and decreases susceptibility to sepsis. Arch Surg 1992; 127: 70-75; discussion 75-76.
16. Yasuda H, Leelahavanichkul A, Tsunoda S et al. Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury. Am J Physiol Renal Physiol 2008; 294: F1050-F1058.
17. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-2169.
18. Tonelli M, Wiebe N, Culleton B et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006; 17: 2034-2047.
19. Thamer M, Ray NF, Fehrenbach SN et al. Relative risk and economic consequences of inpatient care among patients with renal failure. J Am Soc Nephrol 1996; 7: 751-762.
20. Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000; 58: 1758-1764.
21. Shmuely H, Pitlik S, Drucker M et al. Prediction of mortality in patients with bacteremia: the importance of pre-existing renal insufficiency. Ren Fail 2000; 22: 99-108.
22. Naqvi SB, Collins AJ. Infectious complications in chronic kidney disease. Adv Chronic Kidney Dis 2006; 13: 199-204.
23. Parker N, Turk MJ, Westrick E et al. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 2005; 338: 284-293.
24. Foundation NK. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.
25. Garrison RN, Spain DA, Wilson MA et al. Microvascular changes explain the 'two-hit' theory of multiple organ failure. Ann Surg 1998; 227: 851-860.
26. Clancy KD, Lorenz K, Dries D et al. Chlorpromazine modulates cytokine expression in the liver and lung after burn injury and endotoxemia. J Trauma 2000; 48: 215-222; discussion 222-213.
27. Bauhofer A, Lorenz W, Kohlert F et al. Granulocyte colony-stimulating factor prophylaxis improves survival and inflammation in a two-hit model of hemorrhage and sepsis. Crit Care Med 2006; 34: 778-784.
28. Russell JA. Management of sepsis. N Engl J Med 2006; 355: 1699-1713.
29. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004; 351: 159-169.
30. Kang DH, Johnson RJ. Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis. Curr Opin Nephrol Hypertens 2003; 12: 43-49.
31. Pickkers P, Sprong T, Eijk L et al. Vascular endothelial growth factor is increased during the first 48 h of human septic shock and correlates with vascular permeability. Shock 2005; 24: 508-512.
32. van der Flier M, van Leeuwen HJ, van Kessel KP et al. Plasma vascular endothelial growth factor in severe sepsis. Shock 2005; 23: 35-38.
33. Harper SJ, Downs L, Tomson CR et al. Elevated plasma vascular endothelial growth factor levels in non-diabetic predialysis uraemia. Nephron 2002; 90: 341-343.
34. Jacobi J, Porst M, Cordasic N et al. Subtotal nephrectomy impairs ischemia-induced angiogenesis and hindlimb re-perfusion in rats. Kidney Int 2006; 69: 2013-2021.
35. Pawlak K, Pawlak D, Mysliwiec M. Possible association between circulating vascular endothelial growth factor and oxidative stress markers in hemodialysis patients. Med Sci Monit 2006; 12: CR181-CR185.
36. Girndt M, Sester U, Sester M et al. Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant 1999; 14: 2807-2810.
37. Jaber BL. Bacterial infections in hemodialysis patients: pathogenesis and prevention. Kidney Int 2005; 67: 2508-2519.
38. Brandtzaeg P, Osnes L, Ovstebo R et al. Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes. J Exp Med 1996; 184: 51-60.
39. Wolk K, Docke WD, von Baehr V et al. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000; 96: 218-223.
40. Hotchkiss RS, Swanson PE, Freeman BD et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999; 27: 1230-1251.
41. Oberholzer C, Tschoeke SK, Moldawer LL et al. Local thymic caspase-9 inhibition improves survival during polymicrobial sepsis in mice. J Mol Med 2006; 84: 389-395.
42. Weaver JG, Rouse MS, Steckelberg JM et al. Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis. FASEB J 2004; 18: 1185-1191.
43. Wesche-Soldato DE, Chung CS, Lomas-Neira J et al. In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice. Blood 2005; 106: 2295-2301.
44. Eichacker PQ, Natanson C, Danner RL. Surviving sepsis - practice guidelines, marketing campaigns, and Eli Lilly. N Engl J Med 2006; 355: 1640-1642.
45. Bosch RJ, Woolf AS, Fine LG. Gene transfer into the mammalian kidney: direct retrovirus-transduction of regenerating tubular epithelial cells. Exp Nephrol 1993; 1: 49-54.
46. Surendran K, McCaul SP, Simon TC. A role for Wnt-4 in renal fibrosis. Am J Physiol Renal Physiol 2002; 282: F431-F441.
47. Doi K, Hu X, Yuen PS et al. AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality. Kidney Int 2008; 73: 1266-1274.
48. Chen L, Kim SM, Oppermann M et al. Regulation of renin in mice with Cre recombinase-mediated deletion of G protein Gsalpha in juxtaglomerular cells. Am J Physiol Renal Physiol 2007; 292: F27-F37.
49. Kim SM, Chen L, Mizel D et al. Low plasma renin and reduced renin secretory responses to acute stimuli in conscious COX-2-deficient mice. Am J Physiol Renal Physiol 2007; 292: F415-F422.
50. Yuen PS, Dunn SR, Miyaji T et al. A simplified method for HPLC determination of creatinine in mouse serum. Am J Physiol Renal Physiol 2004; 286: F1116-F1119.
51. Standiford TJ, Kunkel SL, Lukacs NW et al. Macrophage inflammatory protein-1 alpha mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. J Immunol 1995; 155: 1515-1524.
52. Dear JW, Yasuda H, Hu X et al. Sepsis-induced organ failure is mediated by different pathways in the kidney and liver: acute renal failure is dependent on MyD88 but not renal cell apoptosis. Kidney Int 2006; 69: 832-836.